Société Aerovate Therapeutics, Inc.
Actions
AVTE
US0080641071
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,66 USD | -0,60% |
|
+6,41% | -92,66% |
18/06 | Les plus fortes baisses du jour | MT |
18/06 | AEROVATE THERAPEUTICS, INC. : Guggenheim neutre sur le dossier | ZM |
Métier
Nombre d'employés: 51
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Benjamin Dake
FOU | Founder | 48 | 27/07/18 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 01/02/21 |
George Eldridge
DFI | Director of Finance/CFO | 61 | 01/03/21 |
Marco Verwijs
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Hunter Gillies
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/20 |
Ralph Niven
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/07/20 |
Timothy Pigot
PRN | Corporate Officer/Principal | - | 01/06/21 |
Sue Fischer
PRN | Corporate Officer/Principal | - | - |
Donna Dea
LAW | General Counsel | - | 01/09/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Donald Santel
BRD | Director/Board Member | 62 | 19/01/23 |
Maha Katabi
BRD | Director/Board Member | 50 | 01/08/20 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 01/02/21 |
Dave Grayzel
BRD | Director/Board Member | 56 | 01/08/20 |
Mark Iwicki
BRD | Director/Board Member | 57 | 01/02/21 |
Joshua Resnick
BRD | Director/Board Member | 49 | 01/10/18 |
Allison Dorval
BRD | Director/Board Member | 48 | 15/07/21 |
Habib Dable
CHM | Chairman | 54 | 10/07/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 28 808 334 | 28 798 566 ( 99,97 %) | 0 | 99,97 % |
Coordonnées société
![Adresse Aerovate Therapeutics, Inc.(AVTE)](https://cdn.zonebourse.com/static/address/124268141.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-92,66% | 47,85 M | |
+38,65% | 39,36 Md | |
-8,62% | 38,52 Md | |
+26,95% | 30,74 Md | |
+10,74% | 25,92 Md | |
-13,50% | 26,03 Md | |
+44,87% | 14,13 Md | |
+34,36% | 12,73 Md | |
-7,14% | 11,29 Md | |
-12,61% | 10,64 Md |
- Bourse
- Actions
- Action AVTE
- Société Aerovate Therapeutics, Inc.